Zum Hauptinhalt springen

Coxsackievirus-Infektion

Hand-Fuß-Mund-Krankheit

Medizinische Fachkräfte

Fachartikel sind für die Nutzung durch Gesundheitsfachkräfte konzipiert. Sie werden von britischen Ärzten verfasst und basieren auf Forschungsergebnissen, britischen und europäischen Richtlinien. Sie finden möglicherweise die Hand-Fuß-Mund-Krankheit Artikel nützlicher oder einer unserer anderen Gesundheitsartikel.

Lesen Sie unten weiter

What is a Coxsackievirus?

The Coxsackieviruses are common pathogens causing a number of diseases, of which the most common is hand, foot and mouth disease (HFMD).

The Coxsackieviruses are RNA viruses of the Picornaviridae -Familie, Enterovirus genus which includes echoviruses and polioviruses. Infections are often asymptomatic. They are divided into groups A and B:

  • Coxsackievirus A:

    • Usually affects skin and mucous membranes.

    • Causes herpangina and HFMD.

    • There are a number of different viruses within the group. The most common causes of HFMD are Coxsackievirus A16 (CA16) along with the closely related enterovirus 71 (EV71).

  • Coxsackievirus B:

    • Usually affects the heart, lungs, pancreas and liver.

    • Causes Bornholm disease, hepatitis, myocarditis and pericarditis.

Coxsackieviruses of both types are a leading cause of aseptic meningitis. They may also cause nonspecific febrile and upper respiratory tract illnesses.

Spread is usually from the faeco-oral route or oral-oral route, with an incubation period of 2-6 days.

The virus is named after the town of Coxsackie in New York State.

Lesen Sie unten weiter

Infection with this group of enteroviruses is very common. In temperate climates, it is most frequent in summer and autumn and, in the tropics, all year round.

Enterovirus disease, particularly HFMD tends to affect those aged under 10 but children of any age and adults can also be affected. It occurs worldwide, both on a sporadic basis and in epidemics. There have been a number of serious outbreaks of HFMD in the Western Pacific region. China has led the quest for vaccines, following a major outbreak with fatalities.

In the UK outbreaks occur regularly in nurseries, schools and childcare centres. Most adults have developed immunity.

Hand-Fuß-Mund-Krankheit1

  • Most often caused by CA16 and the closely related EV71. Subtypes A 6 and 10 can also cause it but it can result from infection with other group A or B viruses.2 3

  • Usually a mild illness with a prodromal phase, followed by tender oral ulcerative lesions and then usually maculopapular lesions on the hands and feet; and sometimes the buttocks.

  • Rarely there are neurological or other complications which can be very severe.

  • Siehe den separaten Artikel Hand-Fuß-Mund-Krankheit für weitere Informationen.

Herpangina4

  • Incubation period of about four days.

  • Affects mainly children up to the age of 10.

  • Mild pyrexia, headache, sore throat, dysphagia, loss of appetite and sometimes vomiting and abdominal pain.

  • Red spots appear on the uvula, soft palate and tonsils which develop into tiny grey-white papulovesicles, about 1 mm or 2 mm in diameter .

  • There is an erythematous halo, which progresses to a shallow ulcer.

  • It is caused mainly by CA16 but can involve other Coxsackievirus A serotypes and occasionally Coxsackievirus B (serotypes 1-5 ).

  • It resolves uneventfully in 5-10 days.

Borholm-Krankheit

  • Usually caused by Coxsackievirus B.

  • Pain on inspiration is similar to pleuritic pain and pulmonary embolism may be suspected. The muscles are locally tender.

  • Fever, headache or nonspecific abdominal pain - either as prodromal symptoms or with the onset of chest pain. May be myalgia elsewhere.

  • Duration is normally a few days, but may be ≤3 weeks; it can recur/relapse.

Siehe den separaten Artikel Borholm-Krankheit.

Myokarditis

  • Coxsackievirus B is one of the more common causes of myocarditis, with potential to progress to dilated cardiomyopathy.5

  • Viral myocarditis may be asymptomatic, or may present with symptoms of heart failure and left ventricular dysfunction.

Siehe den separaten Artikel Myokarditis für weitere Informationen.

Perikarditis

  • Coxsackievirus B is one of the more common causes of pericarditis.

  • The cardinal presenting symptom is Brustschmerzen. Typically, sharp, stabbing, central chest pain.

Aseptic meningitis6

  • Coxsackieviruses are one of the most common causes of aseptic (viral) meningitis.

  • In particular A and B viruses are involved.

  • There is a peak in summer months.

Siehe den separaten Artikel Meningitis für weitere Informationen.

Other clinical conditions

  • Coxsackie A viruses can cause a haemorrhagic conjunctivitis.

  • Coxsackievirus B5 causes pustular stomatitis with Erythema multiforme.

  • Coxsackievirus A4 causes a widespread vesicular eruption.

  • There has been some investigation into Coxsackievirus B4 as a possible part of the aetiology of Typ-1-Diabetes mellitus. There are also possible associations of Coxsackieviruses with postviral fatigue syndromes, Reye's syndrome and Pankreatitis.

  • Coxsackievirus B1 has been reported as causing severe infection and death in neonates in America in 2007-2008.7

Lesen Sie unten weiter

Usually diagnosis is clinical but some laboratory tests are available.

  • Das Virus kann aus Rachen-, Bläschen- oder Rektalabstrichen (in viralen Transportmedien) oder aus einer Stuhlkultur isoliert werden. Die virale Ausscheidung im Stuhl kann intermittierend sein, daher können mehr als eine Probe erforderlich sein.

  • IgM with enzyme-linked immunosorbent assay (ELISA) can aid diagnosis. Blood samples are required in the acute phase because IgM disappears rapidly.

  • Die Polymerase-Kettenreaktion (PCR) hat die Subtypisierung von Enteroviren ermöglicht und wird zunehmend in spezialisierten Zentren als bevorzugter Test eingesetzt, obwohl sie in der routinemäßigen klinischen Praxis selten verwendet wird.

  • There is no known treatment for Coxsackievirus infections, so management is supportive

  • For HFMD/herpangina:

    • Reassurance, and encourage adequate fluid intake.

    • Antipyretic analgesics such as paracetamol and ibuprofen are the main treatment.

    • Topical oral analgesic options are available although there is no evidence of efficacy and some cannot be used by children. Examples are lidocaine oral gel, benzydamine oral rinse or spray, choline salicylate oral gel, warm salty mouthwashes.

  • For other conditions:

    • Antiviral agents are not indicated. There is ongoing research into potential anti-viral agents and several show promise but are not yet at the clinical trial stage. 8

Ratschläge für Schwangere1

  • There are no known adverse consequences for the fetus if a pregnant woman is in contact with HFMD.

  • Seek specialist advice if a woman develops HFMD within three weeks of expected delivery, as there may be a risk of passing the infection to the newborn. In rare cases this can lead to severe infection in the neonate, although usually illness is mild.

  • Coxsackievirus B may cause an increase in early spontaneous abortions, stillbirths and (rarely) fetal myocarditis.9 10

These diseases tend to be self-limiting, although there are occasional case reports of adult fatalities.

The prognosis of HFMD is excellent, with the vast majority resolving spontaneously in 5-10 days. Those cases caused by Coxsackieviruses have less risk of developing neurological complications than those caused by EV17, although they can do very occasionally.

Aseptic meningitis usually resolves without sequelae but encephalitis is more likely to have adverse outcomes.

Although prognosis for those with Coxsackie B myocarditis or pericarditis is generally good, there are risks of complications such as dilated cardiomyopathy, dysrhythmias, cardiac failure and sudden cardiac death.

Good hygiene measures reduce spread of Coxsackieviruses within the family. Advise careful handwashing and drying after using the toilet. Advise against sharing cups, eating utensils, towels and clothing. Advise covering of the mouth and nose when coughing and sneezing, and hygienic disposal of tissues used.

Weiterführende Lektüre und Referenzen

  • Zhang M, Wang H, Tang J, et al; Clinical characteristics of severe neonatal enterovirus infection: a systematic review. BMC Pediatr. 2021 Mar 15;21(1):127. doi: 10.1186/s12887-021-02599-y.
  1. Hand-Fuß-Mund-Krankheit; NICE CKS, September 2024 (nur für UK-Zugang)
  2. Downing C, Ramirez-Fort MK, Doan HQ, et al; Coxsackievirus A6 associated hand, foot and mouth disease in adults: clinical presentation and review of the literature. J Clin Virol. 2014 Aug;60(4):381-6. doi: 10.1016/j.jcv.2014.04.023. Epub 2014 May 9.
  3. Kimmis BD, Downing C, Tyring S; Hand-Fuß-Mund-Krankheit durch Coxsackievirus A6 auf dem Vormarsch. Cutis. 2018 Nov;102(5):353-356.
  4. Herpangina; DermNet NZ
  5. Brunetti L, DeSantis ER; Treatment of viral myocarditis caused by coxsackievirus B. Am J Health Syst Pharm. 2008 Jan 15;65(2):132-7. doi: 10.2146/ajhp060586.
  6. Meningitis - bacterial meningitis and meningococcal disease; NICE CKS, Dezember 2024 (nur für UK-Zugang)
  7. Wikswo ME, Khetsuriani N, Fowlkes AL, et al; Increased activity of Coxsackievirus B1 strains associated with severe disease among young infants in the United States, 2007-2008. Clin Infect Dis. 2009 Sep 1;49(5):e44-51.
  8. Hand, Foot, and Mouth Disease Challenges and Its Antiviral Therapeutics; Vaccines, 2023
  9. Ornoy A, Tenenbaum A; Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. Reprod Toxicol. 2006 May;21(4):446-57. Epub 2006 Feb 9.
  10. Hwang JH, Kim JW, Hwang JY, et al; Coxsackievirus B infection is highly related with missed abortion in Korea. Yonsei Med J. 2014 Nov;55(6):1562-7. doi: 10.3349/ymj.2014.55.6.1562.
  11. Mao Q, Wang Y, Yao X, et al; Coxsackievirus A16: Epidemiologie, Diagnose und Impfstoff. Hum Vaccin Immunother. 2014;10(2):360-7. doi: 10.4161/hv.27087. Epub 2013 Nov 14.
  12. Li L, Yin H, An Z, et al; Considerations for developing an immunization strategy with enterovirus 71 vaccine. Vaccine. 2015 Feb 25;33(9):1107-12. doi: 10.1016/j.vaccine.2014.10.081. Epub 2014 Nov 8.
  13. Liang Z, Wang J; EV71-Impfstoff, ein unschätzbares Geschenk für Kinder. Clin Transl Immunology. 2014 Okt 31;3(10):e28. doi: 10.1038/cti.2014.24. eCollection 2014 Okt.

Lesen Sie unten weiter

Artikelverlauf

Die Informationen auf dieser Seite wurden von qualifizierten Klinikern verfasst und begutachtet.

flu eligibility checker

Fragen, teilen, verbinden.

Durchsuchen Sie Diskussionen, stellen Sie Fragen und teilen Sie Erfahrungen zu Hunderten von Gesundheitsthemen.

symptom checker

Fühlen Sie sich unwohl?

Bewerten Sie Ihre Symptome online kostenlos